Skip to main content



Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Icons
Spotlight Poster Icon
Spotlight Poster Icon
Spotlight Winner
Spotlight Winner

  • Saturday, Aug 27th
    8:00 AM - 8:15 AM CEST
    Use of Antipsychotics and the Risk of Acute Respiratory Failure
    Location: C1M1
    Presenting Author: Onyekachukwu Illoh
    Co-Author: Susan DosReis, FISPE – Pharmaceutical Health Services Research, School of Pharmacy
    Safety End Points
  • Saturday, Aug 27th
    8:00 AM - 9:30 AM CEST
    Safety First!
    Location: C1M1
    Moderator: Almut Winterstein, PhD, FISPE – University of Florida
    Safety End Points
  • Saturday, Aug 27th
    8:30 AM - 8:45 AM CEST
    Association Between Fluoroquinolones and Uveitis, Retinal Detachment and Aortic Aneurysm or Dissection: An Application of Self-controlled Study Designs with Active Comparators
    Location: C1M1
    Presenting Author: Jeremy Brown, MSc – London School of Hygiene and Tropical Medicine
    Co-Author: Kevin Wing – Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT
    Co-Author: Stephen Evans, MSc – Department of Medical Statistics, London School of Hygiene and Tropical Medicine
    Co-Author: Clémence Leyrat – Department of Medical Statistics, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT
    Co-Author: Kathryn Mansfield – London School of Hygiene & Tropical Medicine
    Co-Author: Liam Smeeth – London School of Hygiene and Tropical Medicine
    Co-Author: Angel Wong – London School of Hygiene and Tropical Medicine
    Co-Author: David Yorston – Tennet Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK
    Co-Author: Nicholas Galwey – Research Statistics, GSK, Stevenage, UK
    Co-Author: Ian Douglas, PhD – Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT
    Safety End Points
  • Saturday, Aug 27th
    8:45 AM - 9:00 AM CEST
    Death, Cardiac Event and Acute Liver Injury Associated with Bedaquiline or Delamanid in Patients with Multidrug Resistant Tuberculosis: A Nationwide Cohort Study
    Location: C1M1
    Presenting Author: Han Eol Jeong, MPH, PhD – School of Pharmacy, Sungkyunkwan University
    Co-Author: Ju Hwan Kim, PharmD – School of Pharmacy - Sungkyunkwan University
    Co-Author: Hyesung Lee – Sungkyunkwan University
    Co-Author: In-Sun Oh, PhD – School of Pharmacy, Sungkyunkwan University
    Co-Author: Sungho Bea, PharmD – School of Pharmacy, Sungkyunkwan University
    Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University
    Safety End Points
  • Saturday, Aug 27th
    9:00 AM - 9:15 AM CEST
    Risk of depressive disorders associated with medical cannabis authorization: a propensity score matched cohort study
    Location: C1M1
    Presenting Author: Jerry Liwono Yana, MD, MSc (Candidat) – 1 Faculty of Pharmacy, Université Laval, Quebec City, QC, Canada. 2 Population Health and Optimal Health Practices Research Unit, CHU de Québec, Université Laval Research Centre, Quebec City, QC, Canada
    Co-Author: Jason Dyck – Cardiovascular Research Centre, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
    Co-Author: Dean Eurich – School of Public Health, University of Alberta, Edmonton, AB, Canada
    Co-Author: Arsène Zongo – Population Health and Optimal Health Practices Axis, CHU de Québec-Université Laval Research Center, Québec, Québec, Canada
    Safety End Points
  • Saturday, Aug 27th
    9:15 AM - 9:30 AM CEST
    Risk of Mortality Associated with Pimavanserin Compared with Atypical Antipsychotics in Patients with Parkinson's Disease—related Psychosis
    Location: C1M1
    Presenting Author: J Bradley Layton, PhD, FISPE – RTI Health Solutions
    Co-Author: Lisa McQuay, MBioinf – RTI Health Solutions
    Co-Author: Joan Forns, PhD – RTI Health Solutions
    Co-Author: Heather Danysh, PhD – RTI Health Solutions
    Co-Author: Colleen Dempsey, RN, BSN – Acadia Pharmaceuticals
    Co-Author: Mary Anthony, PhD – RTI Health Solutions
    Co-Author: Mary Ellen Turner, MD, MPH – Acadia Pharmaceuticals
    Safety End Points
  • Saturday, Aug 27th
    1:00 PM - 1:15 PM CEST
    Risk of Venous Thromboembolism in Patients Receiving Targeted Anti-cancer Therapy - A Nationwide Cohort Study
    Location: Congress Hall D2
    Presenting Author: Erzsebet Horvath-Puho
    Co-Author: Florian Moik – Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria
    Co-Author: Cihan Ay – Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria
    Co-Author: John-Bjarne Hansen – Thrombosis Research Center, Department of clinical medicine, UiT – The Arctic university of Norway and University Hospital of North Norway, Tromsø, Norway
    Co-Author: Frits Mulder – Department of Vascular Medicine, Amsterdam Cardiovascular Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Co-Author: Nick van Es – Department of Vascular Medicine, Amsterdam Cardiovascular Science, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Co-Author: Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
    Safety End Points
  • Saturday, Aug 27th
    1:30 PM - 1:45 PM CEST
    Synergistic Effects of PM2.5 and Use of Corticosteroids on Cardiovascular and Thromboembolic Events Among Older Adults: Evidence of Environment-Drug Interaction
    Location: Congress Hall D2
    Presenting Author: Kevin Josey – Harvard School of Public Health
    Co-Author: Rachel Nethery, PhD – Harvard T.H. Chan School of Public Health
    Co-Author: Benjamin Bates – Rutgers Robert Wood Johnson Medical School
    Co-Author: Aayush Visaria – Rutgers University
    Co-Author: Poonam Gandhi – Rutgers University Institute for Health
    Co-Author: Jung Hyun Kim – Rutgers University Institute for Health
    Co-Author: Soko Setoguchi, MD, DrPH, FISPE – Rutgers Robert Wood Johnson Medical School
    Safety End Points
  • Saturday, Aug 27th
    1:45 PM - 2:00 PM CEST
    Association Between Phentermine and Risk of Major Adverse Cardiovascular Events: A Suite of Self-Controlled and Comparative Cohort Studies to Conquer Confounding
    Location: Congress Hall D2
    Presenting Author: Amir Sarayani, PharmD, MPH, PhD – University of Florida Department of Pharmaceutical Outcomes and Policy
    Co-Author: Christian Hampp, PhD, FISPE – Regeneron Pharmaceuticals
    Co-Author: William T. Donahoo, MD – 4. Division of Endocrinology, Diabetes, & Metabolism, College of Medicine, University of Florida
    Co-Author: Joshua Brown, PharmD, PhD – Center for Drug Evaluation and Safety, Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL USA
    Co-Author: Almut Winterstein, PhD, FISPE – University of Florida
    Safety End Points
  • Saturday, Aug 27th
    2:00 PM - 2:15 PM CEST
    Use of Chlorprothixene and the Risk of Diabetes and Major Adverse Cardiovascular Events: A Nation-wide Cohort Study
    Location: Congress Hall D2
    Presenting Author: Jesper Hallas, MD, PhD, FISPE – University of Southern Denmark
    Co-Author: Rikke Wesselhoeft – University of Southern Denmark
    Co-Author: Mikkel Hoejlund, MD – University of Southern Denmark
    Co-Author: Christina Wagner – Mental Health Center Glostrup, Copenhagen University Hospital, Mental Health Services CPH, Copenhagen, Denmark
    Co-Author: Kjeld Andersen, MD PhD MSc – Department of Psychiatry Odense – University Clinic, Mental Health Services in the Region of Southern Denmark, Odense, Denmark
    Co-Author: Anders Fink-Jensen – Psychiatric Centre Copenhagen, Mental Health Services in the Capital Region of Denmark, Copenhagen, Denmark
    Safety End Points
  • Saturday, Aug 27th
    2:00 PM - 2:15 PM CEST
    Sodium-glucose Co-transporter 2 Inhibitors and the Risk of Early Bladder Cancer Events
    Location: Congress Hall D5
    Presenting Author: Devin Abrahami, PhD – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Helen Tesfaye – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Co-Author: Hui Yin, MSc – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada
    Co-Author: Seanna Vine – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Co-Author: Blánaid Hicks – Queen’s University Belfast, Belfast, Northern Ireland
    Co-Author: Oriana Yu – Division of Endocrinology, Jewish General Hospital, Montreal, Québec, Canada
    Co-Author: Robert W. Platt, PhD – McGill Dept of Epidemiology, Biostatistics and Occupational Health
    Co-Author: Sebastian Schneeweiss, ScD, MD, FISPE – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
    Co-Author: Elisabetta Patorno – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Co-Author: Laurent Azoulay, PhD – McGill University, Montreal, Quebec, Canada
    Safety End Points
  • Saturday, Aug 27th
    2:15 PM - 2:30 PM CEST
    Use of Combined Oral Contraceptives and Risk of Venous Thromboembolism: A Nested Case-control Analysis in German Claims Data
    Location: Congress Hall D2
    Presenting Author: Tania Schink – Leibniz Institute for Prevention Research and Epidemiology - BIPS
    Co-Author: Christina Princk – Leibniz Institute for Prevention Research and Epidemiology - BIPS
    Co-Author: Malte Braitmaier – Department of Biometry and Data Management, Leibniz-Institut für Präventionsforschung und Epidemiologie - BIPS
    Co-Author: Ulrike Haug – Leibniz Institute for Prevention Research and Epidemiology - BIPS
    Safety End Points
  • Saturday, Aug 27th
    2:15 PM - 2:30 PM CEST
    Thiazide Diuretics and Risk of Colorectal Cancer
    Location: Congress Hall D5
    Presenting Author: Julie Rouette, MSc PhD(c) – McGill Dept of Epidemiology, Biostatistics and Occupational Health
    Co-Author: Emily McDonald, MD MSc – Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal
    Co-Author: Tibor Schuster, PhD – Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal
    Co-Author: ilan Matok – Division of Clinical Pharmacy, the Hebrew University of Jerusalem, Jerusalem
    Co-Author: James Brophy, MD PhD – Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal
    Co-Author: Laurent Azoulay, PhD – McGill University, Montreal, Quebec, Canada
    Safety End Points
  • Sunday, Aug 28th
    8:30 AM - 8:45 AM CEST
    Validation of an International Classification of Disease (ICD) 10 Algorithm for Hypoglycemia in Administrative Claims Data
    Location: Congress Hall D5
    Presenting Author: Qoua Her, PharmD, MSc – University of North Carolina at Chapel Hill
    Co-Author: Sara Dejene, MSPH – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
    Co-Author: Jea Young Min, PhD, PharmD – Department of Population Health Sciences, Weill Cornel Medical College
    Co-Author: Virginia Pate, MS – University of North Carolina at Chapel Hill
    Co-Author: Michele Jonsson Funk, PhD, FISPE – UNC Gillings School of Global Public Health
    Co-Author: James Flory, MD, MSCE – Endocrinology Service, Department of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center
    Safety End Points
  • Sunday, Aug 28th
    1:30 PM - 1:45 PM CEST
    Long-acting Insulin Analogues versus Neutral Protamine Hagedorn Insulin and the Risk of Severe Hypoglycemia Among Patients in Type 2 Diabetes in the United Kingdom
    Location: C1M0
    Presenting Author: Vanessa C. Brunetti, PhD – McGill Dept of Epidemiology, Biostatistics and Occupational Health
    Co-Author: Kristian Filion, PhD – McGill University
    Co-Author: Oriana Hoi Yun Yu, MD, MSc – McGill University
    Co-Author: Robert W. Platt, PhD – McGill Dept of Epidemiology, Biostatistics and Occupational Health
    Safety End Points
  • Sunday, Aug 28th
    1:30 PM - 3:00 PM CEST
    Safety Issues Concerning DM and Antidiabetic Drugs
    Location: C1M0
    Moderator: Han Eol Jeong, MPH, PhD – School of Pharmacy, Sungkyunkwan University
    Moderator: Sonal Singh, MD, MPH – UMass Chan Medical School
    Safety End Points
  • Sunday, Aug 28th
    2:00 PM - 2:15 PM CEST
    The Comparative Safety of Individual SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis
    Location: C1M0
    Presenting Author: Devin Abrahami, PhD – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Elvira D'Andrea – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Seoyoung Kim, MD, DSc – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
    Co-Author: Deborah Wexler, MD MSc – Massachusetts General Hospital
    Co-Author: Julie M. Paik, MD, ScD – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Elisabetta Patorno – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Safety End Points
  • Sunday, Aug 28th
    2:30 PM - 2:45 PM CEST
    The Difference Between Pregabalin and Gabapentin in the Risk of Fragility Fractures - A Nationwide High-dimensional Propensity Score Matched Cohort Study
    Location: Congress Hall D2
    Presenting Author: Daniel Pilsgaard Henriksen – University of Southern Denmark
    Co-Author: Emilie Jørgensen – Department of Clinical Pharmacology, Odense University Hospital
    Co-Author: Per Damkier, MD, PhD – Department of Clinical Pharmacology, Odense University Hospital, Denmark and Department of Clinical Research, University of Southern Denmark, Denmark
    Co-Author: Jesper Hallas, MD, PhD, FISPE – University of Southern Denmark
    Safety End Points
  • Sunday, Aug 28th
    2:30 PM - 2:45 PM CEST
    Risk of Hypoglycemia with Sodium Glucose cotransporter-2 Inhibitors vs. Alternative Glucose Lowering Medications in Patients with and Without Baseline Use of Insulin or Sulfonylurea
    Location: C1M0
    Presenting Author: Phyo T. Htoo – Brigham and Women's Hospital/Harvard Medical School
    Co-Author: Deborah Wexler, MD MSc – Massachusetts General Hospital
    Co-Author: Seoyoung Kim, MD, DSc – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
    Co-Author: Julie M. Paik, MD, ScD – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Ethan Alt – Brigham and Women's Hospital
    Co-Author: Dae Kim – Brigham and Women's Hospital
    Co-Author: Elisabetta Patorno – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
    Safety End Points
  • Sunday, Aug 28th
    2:45 PM - 3:00 PM CEST
    Concomitant Use of Sulfonylureas and Warfarin and the Risk of Severe Hypoglycemia: A Population-based Cohort Study
    Location: C1M0
    Presenting Author: Jenny Dimakos – McGill University, Department of Medicine
    Co-Author: Ying Cui – Centre for Clinical Epidemiology, Lady Davis Institute
    Co-Author: Robert W. Platt, PhD – McGill Dept of Epidemiology, Biostatistics and Occupational Health
    Co-Author: Christel Renoux, MD PhD – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
    Co-Author: Kristian Filion, PhD – McGill University
    Co-Author: Antonios Douros, MD, Dr – Lady Davis Institute
    Safety End Points